Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7WWM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,824
Award facts
- Contract value 100% obligated
- $15,824.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $15,824.00 by the Defense Logistics Agency on January 15, 2026, with an ultimate completion date of January 16, 2026. The contract covers the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL), a diabetes medication commonly used in military and veteran healthcare systems. This award was made through open competition with no set-aside designation and represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at up to $999,999,999.00 and extends through December 2026.
The delivery order falls within AmerisourceBergen's established role as a critical pharmaceutical vendor for the Defense Logistics Agency's medical supply chain. The company's parent organization, Cencora, Inc. (doing business as AmerisourceBergen), maintains an even larger IDC with DLA valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific order for Trulicity reflects the company's extensive portfolio in delivering specialized medications across multiple therapeutic domains to federal medical institutions, including military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F7WWM?
SPE2DR26F7WWM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F7WWM worth?
The government has obligated $15,824 on SPE2DR26F7WWM.
Is contract SPE2DR26F7WWM an order under another contract?
Yes. SPE2DR26F7WWM is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WWM competed?
The extent of competition for SPE2DR26F7WWM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award